Galera Announces Plan to Submit Avasopasem NDA by Year End

Author's Avatar
Jul 05, 2022

After discussions with FDA, Company is on track to file an NDA for avasopasem for the treatment of radiotherapy-induced severe oral mucositis by end of 2022